TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in TScan Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- +22 vs. Q3 2023
- Shares held
- 31.9M
- +3.32M (+11.6%) vs. Q3 2023
- Total value
- $186.1M
- +$112.9M (+154.2%) vs. Q3 2023
- New holders
- 22
- 12 more added
- Sold out
- 0
- 5 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 43 | $251 | 0.00% | +43 | New |
| Wells Fargo & Company | 301 | $1.75K | 0.00% | +15+5.2% | Added |
| Atlas Capital Advisors LLC | 896 | $5.22K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,424 | $8.30K | 0.00% | +309+27.7% | Added |
| Lazard Asset Management LLC | 3,983 | $22.0K | 0.00% | +3,983 | New |
| Aries Wealth Management | 10,000 | $58.3K | 0.02% | 00.0% | Unchanged |
| Waldron Private Wealth LLC | 10,000 | $58.3K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 13,293 | $77.5K | 0.00% | +13,293 | New |
| Y-Intercept (Hong Kong) Ltd | 15,005 | $87.5K | 0.01% | +15,005 | New |
| Privium Fund Management (UK) Ltd | 15,825 | $92.3K | 0.06% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 16,670 | $97.2K | 0.00% | +16,670 | New |
| Walleye Capital LLC | 17,777 | $103.6K | 0.00% | +17,777 | New |
| Virtu Financial LLC | 18,418 | $107.0K | 0.01% | +18,418 | New |
| Letko, Brosseau & Associates Inc | 20,700 | $120.7K | 0.00% | −11,700−36.1% | Reduced |
| American Century Companies Inc | 21,315 | $124.3K | 0.00% | +2,103+10.9% | Added |
| Pale Fire Capital SE | 21,573 | $125.8K | 0.02% | +4,998+30.2% | Added |
| Renaissance Technologies LLC | 21,700 | $127.0K | 0.00% | +4,000+22.6% | Added |
| Charles Schwab Investment Management Inc | 22,104 | $128.9K | 0.00% | +22,104 | New |
| Cubist Systematic Strategies, LLC | 26,245 | $153.0K | 0.00% | +26,245 | New |
| Goldman Sachs Group Inc | 30,285 | $176.6K | 0.00% | +30,285 | New |
| JPMorgan Chase & Co | 33,230 | $193.7K | 0.00% | +33,230 | New |
| DC Investments Management, LLC | 35,563 | $207.3K | 0.21% | 00.0% | Unchanged |
| Bank of America Corp | 37,804 | $220.4K | 0.00% | +37,604+18,802.0% | Added |
| 683 Capital Management, LLC | 43,198 | $251.8K | 0.03% | +43,198 | New |
| Balyasny Asset Management LLC | 45,986 | $268.1K | 0.00% | +45,986 | New |
| Man Group plc | 50,410 | $293.9K | 0.00% | +50,410 | New |
| Laurion Capital Management LP | 60,400 | $352.1K | 0.01% | +60,400 | New |
| State Street Corp | 61,100 | $356.2K | 0.00% | +19,400+46.5% | Added |
| ExodusPoint Capital Management, LP | 63,778 | $372.0K | 0.00% | +63,778 | New |
| Northern Trust Corp | 71,611 | $417.5K | 0.00% | −365−0.5% | Reduced |
| Citigroup Inc | 73,163 | $426.5K | 0.00% | +73,163 | New |
| Qube Research & Technologies Ltd | 79,989 | $466.3K | 0.00% | +77,579+3,219.0% | Added |
| Jane Street Group, LLC | 83,622 | $487.5K | 0.00% | +83,622 | New |
| Bridgeway Capital Management, LLC | 88,300 | $514.8K | 0.01% | 00.0% | Unchanged |
| NewEdge Wealth, LLC | 91,463 | $533.2K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 99,082 | $577.6K | 0.00% | +99,082 | New |
| Susquehanna International Group, LLP | 103,948 | $606.0K | 0.00% | +87,033+514.5% | Added |
| Marshall Wace, LLP | 110,551 | $644.5K | 0.00% | +110,551 | New |
| Stifel Financial Corp | 120,400 | $701.9K | 0.00% | +3,500+3.0% | Added |
| Standard Life Aberdeen plc | 200,000 | $1.17M | 0.00% | +200,000 | New |
| Morgan Stanley | 234,703 | $1.37M | 0.00% | −24,744−9.5% | Reduced |
| Geode Capital Management, LLC | 391,646 | $2.28M | 0.00% | +83,708+27.2% | Added |
| DC Funds, LP | 630,000 | $3.67M | 44.16% | 00.0% | Unchanged |
| Simplify Asset Management Inc. | 1,046,916 | $6.10M | 0.95% | 00.0% | Unchanged |
| Alphabet Inc. | 1,077,080 | $6.28M | 0.29% | 00.0% | Unchanged |
| Deer Management Co. LLC | 1,245,505 | $7.26M | 0.94% | 00.0% | Unchanged |
| BlackRock Inc. | 1,671,727 | $9.75M | 0.00% | −8,722−0.5% | Reduced |
| Vanguard Group Inc | 1,788,152 | $10.4M | 0.00% | +35,558+2.0% | Added |
| Propel Bio Management, LLC | 2,087,139 | $12.2M | 10.09% | +2,087,139 | New |
| Baker Bros. Advisors LP | 2,784,792 | $16.2M | 0.18% | 00.0% | Unchanged |
| BVF Inc | 2,989,474 | $17.4M | 0.44% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 3,900,000 | $22.7M | 0.05% | −100,000−2.5% | Reduced |
| EcoR1 Capital, LLC | 5,000,000 | $29.1M | 0.76% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 5,224,600 | $30.5M | 11.98% | 00.0% | Unchanged |